J3111 Injection. romosozumab-aqqg 1 milligrams
Also known as: romosozumab, Evenity, sclerostin inhibitor
Romosozumab-aqqg (Evenity) 1 milligram injection is a humanized monoclonal antibody that inhibits sclerostin for osteoporosis treatment with rapid bone formation.
In Plain Language
bone-strengthening injection; osteoporosis shot
Clinical Context
Indicated for postmenopausal osteoporosis in women at high fracture risk. Inhibits sclerostin to promote bone formation and reduce bone resorption. Administered monthly via subcutaneous injection for 12 months.
RVU Information
CPT J3111 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J3111?
CPT J3111 (Injection. romosozumab-aqqg 1 milligrams) is a J Codes (Drugs) code. Romosozumab-aqqg (Evenity) 1 milligram injection is a humanized monoclonal antibody that inhibits sclerostin for osteoporosis treatment with rapid bone formation.
How is J3111 administered?
CPT J3111 is administered by a healthcare provider, typically via injection or infusion. Indicated for postmenopausal osteoporosis in women at high fracture risk. Inhibits sclerostin to promote bone formation and reduce bone resorption. Administered monthly via subcutaneous injection for 12 months. It is used by Endocrinology, Rheumatology, Orthopedic Surgery.
When is CPT J3111 used?
Indicated for postmenopausal osteoporosis in women at high fracture risk. Inhibits sclerostin to promote bone formation and reduce bone resorption. Administered monthly via subcutaneous injection for 12 months.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.